rs11638815
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs11638815(A;A) |
Make rs11638815(A;C) |
Make rs11638815(C;C) |
Reference | GRCh38 38.1/141 |
Chromosome | 15 |
Position | 82683530 |
Gene | AP3B2, CPEB1-AS1 |
is a | snp |
is | mentioned by |
dbSNP | rs11638815 |
dbSNP (classic) | rs11638815 |
ClinGen | rs11638815 |
ebi | rs11638815 |
HLI | rs11638815 |
Exac | rs11638815 |
Gnomad | rs11638815 |
Varsome | rs11638815 |
LitVar | rs11638815 |
Map | rs11638815 |
PheGenI | rs11638815 |
Biobank | rs11638815 |
1000 genomes | rs11638815 |
hgdp | rs11638815 |
ensembl | rs11638815 |
geneview | rs11638815 |
scholar | rs11638815 |
rs11638815 | |
pharmgkb | rs11638815 |
gwascentral | rs11638815 |
openSNP | rs11638815 |
23andMe | rs11638815 |
SNPshot | rs11638815 |
SNPdbe | rs11638815 |
MSV3d | rs11638815 |
GWAS Ctlg | rs11638815 |
GMAF | 0.2002 |
Max Magnitude | 0 |
? | (A;A) (A;C) (C;C) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23118302] |
Trait | Lipoprotein-associated phospholipase A2 activity change in response to statin therapy |
Title | Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy. |
Risk Allele | C |
P-val | 1E-6 |
Odds Ratio | 4.10 [2.14-6.06] nmol/min/ml increase |